Skip to content

Addiction: all studies

Page 250 of 855: studies 2,491 to 2,500 of 8,547, newest first. Back to the addiction overview

Research

3,4-Methylenedioxymethamphetamine (MDMA) does not induce robust psychomotor activation and 50-kHz ultrasonic vocalisations in tryptophan hydroxylase 2 (Tph2)-deficient rats lacking serotonin in the central nervous system.

British Journal of Pharmacology November 23, 2025 Tianhua Wang, Rainer K.W. Schwarting, Markus Wöhr 1 citation

3,4-Methylenedioxymethamphetamine (MDMA), commonly known as ecstasy, is a psychostimulant with entactogenic properties and known to induce arousal and euphoria. As an amphetamine derivate, MDMA acts on the monoamine systems in the brain and stimulates release of dopamine (DA), noradrenaline (NA) and serotonin (5-HT), yet their individual contributions in driving arousal and euphoria remain...

DOI: 10.1111/bph.70226 (opens in new tab) Full text (opens in new tab) Locomotor activity Psychostimulant Tryptophan hydroxylase 2 Ecstasy effects: ecstasy +13

Chomsky’s concept of mind

Empedocles: European Journal for the Philosophy of Communication November 21, 2025 M. A. Tantray, Ifrah Mohiuddin

The nature, location and functioning of the human mind remain contentious topics among philosophers, psychologists, linguists and AI researchers. Noam Chomsky, a pivotal figure in the cognitive revolution, offers a comprehensive framework for understanding the mind’s structure, processes and interactions with cognitive modules. This paper explores Chomsky’s perspective on the mind’s capacities,...

Acute experiences and persisting psychological effects associated with an encapsulated DMT-harmala alkaloid combination: results of a phase 1 study.

Scientific Reports November 20, 2025 Daniel Perkins, Andreas Halman, Anna Urokohara et al.

Acute subjective experiences induced by psychedelics have been identified as important mediators of therapeutic outcomes in many studies. Mystical experiences specifically, have been correlated with a range of therapeutic outcomes including reductions in symptoms of depression, anxiety and addiction. This paper assesses acute subjective experiences induced by an encapsulated DMT-harmala...

DOI: 10.1038/s41598-025-25767-x (opens in new tab) Full text (opens in new tab) Clinical study Harmala Mystical experiences Psychedelics: DMT +20

Attention and meditative development: A review and synthesis of long-term meditators and outlook for the study of advanced meditation.

Neuroimage November 19, 2025 Sebastian Ehmann, Idil Sezer, Arielle S Keller et al. 2 citations

Attention regulation is a core mechanism of mindfulness meditation and has been proposed to underlie many of its health-related benefits. Here, we review and synthesize behavioral findings on attentional outcomes in long-term meditators, integrating neurocognitive evidence within a meditative development framework. Key findings indicate trait-level improvements across attentional...

A qualitative study of long-term members of ayahuasca spiritual communities in the United States: Motivations, practices, experiences and beliefs

Journal of Psychedelic Studies November 18, 2025 Joseph T. la Torre, Ariana Kam, Todd Youngs et al.

This novel qualitative study examines the lived experiences of long-term participants in ayahuasca spiritual communities (ASCs) in the United States. Semi-structured interviews ( n = 11) were analyzed using reflexive thematic analysis indicating that these communities (1) attract individuals seeking healing from trauma, addiction, and psychological distress, while offering a sense of belonging...

Response of iPSC-derived neurons from individuals with treatment-resistant depression to (2 R,6 R)-hydroxynorketamine and reelin: an exploratory study.

Translational Psychiatry November 18, 2025 Jenessa N Johnston, Peixiong Yuan, Bashkim Kadriu et al. 2 citations

Treatment-resistant depression (TRD) is associated with worse clinical outcomes and longer course of illness. However, TRD is more difficult to model in animal phenotypes, suggesting that other experimental and translational models must be considered to properly address and research novel therapeutics. Reelin, an endogenous glycoprotein downregulated in depression, has shown rapid...

Nightmare frequency mediates the association between childhood trauma and suicidal ideation among youth: is it sex-specific?

European Archives of Psychiatry and Clinical Neuroscience November 17, 2025 Jianyu Que, Yan’e Lu, Jingrou Liu et al.

Childhood trauma has been found to be associated with suicidal ideation among youth. However, the underlying processes that link childhood trauma and suicidal ideation are unclear. This study investigates the role of nightmare frequency in the association between childhood trauma and suicidal ideation, and the potential moderating effect of sex. Youths were recruited from Fujian Province,...

DOI: 10.1007/s00406-025-02149-y (opens in new tab) Full text (opens in new tab) Nightmare Suicidal ideation Association psychology Mediation +6

Buddhism, Consciousness, and the (Im)Possibility of Ethical AI

Contemporary Buddhism November 16, 2025 Martin T. Adam

ABSTRACT This article explores the relevance of classical Theravāda Buddhist doctrine to the present-day development of artificial general intelligence. Specifically, it addresses the interconnected possibilities of machine consciousness and machine agency. The first section consists of a philosophical exploration of the notion of artificial consciousness in light of ordinary language...

Age- and estrous-dependent effects of psilocybin in rats.

Neuropharmacology November 15, 2025 Alexia L Zylko, Ryan J. Rakoczy, Brianna F Roberts et al. 4 citations

Psilocybin, a psychedelic compound in "magic" mushrooms, has promise as a novel treatment for psychiatric disorders, many of which are more prevalent in females and have onsets during adolescence. However, there is a lack of research about how factors such as sex and age affect responses to psilocybin, as well as potential safety concerns with developmental exposure. The primary objectives of...

Qualitative insights into psilocybin and LSD experiences: Enhanced connection and emotion processing reported by Spanish-speaking survey respondents

Psychedelics November 15, 2025 Meghan DellaCrosse, Shoval Gilead, Rafael Lancelotta et al.

Serotonergic psychedelics like psilocybin and LSD have shown potential therapeutic benefits for mental health conditions, including depression, PTSD, and addiction. However, research remains limited due to regulatory barriers and a lack of diversity in study populations. Spanish-speaking individuals, despite their significant global and U.S. presence, are underrepresented in psychedelic...

DOI: 10.1016/j.psyche.2025.100004 (opens in new tab) Psilocybin Generalizability theory Thematic analysis Mental health +11